Follow the biology

The biological rationale for using phosphate binders early in chronic kidney disease is straightforward: disruption of phosphate homeostasis is an early manifestation of the disease, and buildup of serum phosphorus leads to deleterious effects in patients long before they start dialysis.

Indeed, the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend early screening and treatment for hyperphosphatemia...